Zhitao Ying Selected Research

Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)

1/2018

The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhitao Ying Research Topics

Disease

10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 12/2013
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 01/2014
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2021
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2022 - 01/2020
4	Neoplasms (Cancer) 08/2021 - 01/2018
4	T-Cell Lymphoma (Lymphoma, T Cell) 01/2019 - 07/2013
3	Extranodal NK-T-Cell Lymphoma 09/2018 - 07/2013
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 04/2015
2	Hodgkin Disease (Hodgkin's Disease) 03/2024 - 04/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 01/2018
2	Cytokine Release Syndrome 01/2021 - 01/2019
2	Liver Diseases (Liver Disease) 09/2018 - 02/2017
2	Hypersensitivity (Allergy) 09/2018 - 02/2017
1	Adenocarcinoma 09/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Neutropenia 02/2017
1	Disseminated Intravascular Coagulation 12/2016
1	Lymphoma (Lymphomas) 12/2016
1	Infections 09/2015
1	Proteinuria 01/2014
1	Hemorrhage 01/2014
1	Heart Failure 01/2014

Drug/Important Bio-Agent (IBA)

9	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2019
4	relmacabtagene autoleucelIBA 01/2023 - 01/2021
4	Rituximab (Mabthera)FDA Link 01/2020 - 12/2013
4	Vincristine (Oncovin)FDA LinkGeneric 01/2019 - 07/2013
4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 07/2013
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2018 - 07/2013
3	Asparaginase (Elspar)FDA Link 09/2018 - 07/2013
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2018 - 04/2014
2	camrelizumabIBA 03/2024 - 01/2023
2	ibrutinibIBA 02/2019 - 01/2018
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2018 - 02/2017
2	Fibrinogen (Factor I)FDA Link 09/2018 - 02/2017
1	Gemcitabine FDA Link 03/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024
1	apatinibIBA 01/2023
1	Histone Deacetylase InhibitorsIBA 08/2021
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 08/2021
1	Therapeutic UsesIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	enzastaurinIBA 02/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Prednisolone (Predate)FDA LinkGeneric 09/2018
1	Everolimus FDA Link 01/2018
1	PLS-123IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	pegaspargase (Oncaspar)FDA Link 02/2017
1	Fluorine-18IBA 01/2017
1	Prednisone (Sone)FDA LinkGeneric 01/2017
1	Serum AlbuminIBA 12/2016
1	BilirubinIBA 12/2016
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2016
1	Immunoglobulin Variable RegionIBA 09/2015
1	Surface Antigens (Surface Antigen)IBA 09/2015
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2015
1	Bevacizumab (Avastin)FDA Link 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2013

Therapy/Procedure

12	Therapeutics 03/2024 - 01/2014
4	Drug Therapy (Chemotherapy) 02/2019 - 12/2017
3	Radiotherapy 09/2018 - 07/2013
2	Immunotherapy 01/2022 - 02/2021
1	Hematopoietic Stem Cell Transplantation 02/2019
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2018
1	Transplantation 12/2017
1	Stem Cell Transplantation 12/2017
1	VAP-cyclo protocol 01/2014